SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Vivanza Biosciences Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
530057 INE984E01035 1.12525 Not Listed 0 8.36 0 0 1
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales53.737.820.17
Other Operating Income0.000.000.00
Other Income 0.010.020.02
Total Income53.747.840.19
Total Expenditure 53.237.741.07
PBIDT0.510.10-0.88
Interest 0.050.080.08
PBDT0.470.02-0.96
Depreciation0.000.000.00
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax0.460.02-0.97
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.460.02-0.97
    
EPS (Unit Curr.)0.120.00-0.24
EPS (Adj) (Unit Curr.)0.120.00-0.24
Calculated EPS (Unit Curr.)0.120.00-0.24
Calculated EPS (Adj) (Unit Curr.)0.120.00-0.24
Calculated EPS (Ann.) (Unit Curr.)0.460.02-0.97
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.460.02-0.97
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity4.004.004.00
Reserve & Surplus0.500.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)0.951.28-517.65
PBDTM(%)0.870.26-564.71
PATM(%)0.860.26-570.59